Development of Hedgehog Pathway Inhibitors (HPI) in Treatment of Cancer

Publisher： Bentham Science Publishers

E-ISSN： 1874-4796|8|3|132-148

ISSN： 1872-3136

Source： Current Chemical Biology, Vol.8, Iss.3, 2014-12, pp. : 132-148

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Toward Inhibitors of Protein Tyrosine Phosphatases for Cancer Treatment

By  

Current Enzyme Inhibition, Vol. 4, Iss. 1, 2008-01 ,pp. : 1-9

Bentham Science Publishers

Access to resources Recommend Favorite

Development of Inhibitors of the Aspartyl Protease Renin for the Treatment of Hypertension

By  

Current Protein and Peptide Science, Vol. 7, Iss. 3, 2006-06 ,pp. : 241-254

Bentham Science Publishers

Access to resources Recommend Favorite

Quinazoline-urea, new protein kinase inhibitors in treatment of prostate cancer

By Garofalo Antonio   Goossens Laurence   Lemoine Amelie   Farce Amaury   Arlot Yannick   Depreux Patrick  

Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 25, Iss. 2, 2010-04 ,pp. : 158-171

Informa Healthcare

Access to resources Recommend Favorite

iNOS/COX-2 Pathway Interaction: A Good Molecular Target for Cancer Treatment

By  

Current Enzyme Inhibition, Vol. 1, Iss. 2, 2005-06 ,pp. : 97-105

Bentham Science Publishers

Access to resources Recommend Favorite

Suppressors of hedgehog signaling: Linking aberrant development of neural progenitors and tumorigenesis

By Marcotullio Lucia   Ferretti Elisabetta   Smaele Enrico   Screpanti Isabella   Gulino Alberto  

Molecular Neurobiology, Vol. 34, Iss. 3, 2006-12 ,pp. : 193-204

Humana Press, Inc

Access to resources Recommend Favorite